<DOC>
	<DOCNO>NCT00005013</DOCNO>
	<brief_summary>The purpose trial study acute efficacy safety standardize extract herb Hypericum perforatum ( St. John 's Wort ) , call hypericum purpose trial , treatment patient major depression . Clinical depression serious medical disorder debilitate lead suicide . There grow public interest claim hypericum may effective treatment depression . Although widely prescribe Europe , study long-term use conduct , publish study treat different type patient use several different dos . The toxicity side effect hypericum appear substantially less standard tricyclic antidepressant medication , thus hypericum may acceptable patient . In addition , cost significantly less standard antidepressant medication . Published study assess acute efficacy last 4 12 week ( 4-6 week ) . The longer-term effect hypericum evaluate . There need large-scale , control clinical trial ass whether Hypericum significant therapeutic effect patient clinical depression . Patients assign randomly ( like toss coin ) receive St. John 's wort , Sertraline ( Zoloft ) , placebo ( sugar pill ) 8 week . This double-blind study , mean neither patient doctor know treatment assign . Patients respond well treatment continue assign treatment additional 4 month . Patients regular follow-up visit monitor symptoms side effect experience .</brief_summary>
	<brief_title>Treatment Major Depression With St. John 's Wort ( Hypericum )</brief_title>
	<detailed_description>This trial determine acute antidepressant efficacy standardize extract hypericum ( St. John 's Wort ) treatment major depressive disorder . For trial , primary efficacy analysis evaluate 8 week . For observational purpose , 4-month double blind continuation ( 6 month total treatment ) treatment responder would enable approximation effectiveness maintenance treatment medication . No published study include selective serotonin re-uptake inhibitor ( SSRI ) comparator . While trial compare efficacy hypericum SSRI , SSRI arm sertraline ( Zoloft ) allow evaluation validity trial . 336 eligible patient randomly assign double-blind treatment hypericum , sertraline , placebo follow one-week placebo lead-in period ( screen baseline ) . All treatment group consist 112 patient follow eight-week period . Treatment responder continue randomly assign treatment arm additional 18 week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Major depression assess Structured Clinical Interview DSMIV Axis I Disorders ( SCID ; First et al , 1995 ) Minimum score great equal 20 17item Hamilton Depression ( HAMD ) Scale screen baseline GAF 60 less ( moderate symptom ) screen baseline HAMD decrease 25 % screen baseline Capacity give inform consent follow study procedure . Abstinence effective method contraception throughout study Scores great 2 `` suicide '' item HAMD , history suicide attempt ( ) past 12 month Current suicidal homicidal risk , determine investigator Women childbearing age pregnant , plan pregnancy next 6 month , breastfeeding , use medically acceptable mean birth control ( hormonal treatment birth control pill , injection implant , IUD , double barrier condom diaphragm together acceptable ; primary use condom , sponge diaphragm alone ( single barrier ) acceptable may carry high rate failure use alone Clinically significant liver disease ( hepatitis , cirrhosis , etc ) ; clinically significant elevation liver enzyme test ( two time upper limit normal ; asymptomatic Gilbert 's syndrome exclusion ) . 4 . Serious unstable medical illness . 5 . History seizure disorder ( febrile ) . Any follow DSMIV diagnose SCID : current ( within past 6 month ) alcohol substance abuse disorder ; schizophrenia , schizoaffective , psychotic disorder ; bipolar disorder ; current panic disorder obsessive compulsive disorder ; history psychotic feature affective disorder ( mood congruent incongruent ) Clinical laboratory evidence untreated unstable thyroid disorder Failed respond least two adequate antidepressant trial ( define 6 week treatment either great equal 150 mg imipramine , tricyclic equivalent ) , great equal 60 mg phenelzine , MAOI equivalent , great equal 100 mg sertraline , SSRI equivalent Have take sertraline form hypericum current episode depression dose level , daily , least one month , within past 6 month Current ( within past 6 month ) use prescription nonprescription drug , include anticonvulsant medication significant psychotropic property , antiretroviral medication , cyclosporine , digoxin , coumadin , dietary supplement , natural remedy , botanical preparation ( eg , hypericum , kava , valerian ) Have investigational drug within 30 day psychotropic medication within 21 day baseline ( 6 week fluoxetine ) Known allergy hypersensitivity study medication Positive drug urine screen Have psychotherapy 2 month less time enrollment study Receiving psychotherapy specifically design treat depression , eg , interpersonal psychotherapy study period Mental retardation cognitive impairment , disorder might interfere ability consent follow study procedure requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Antidepressive Agents</keyword>
	<keyword>Depression</keyword>
	<keyword>Depressive Disorder</keyword>
	<keyword>Herbs</keyword>
	<keyword>Hypericum</keyword>
	<keyword>Medicine , Herbal</keyword>
	<keyword>Plant Extracts</keyword>
	<keyword>Alternative Medicine</keyword>
</DOC>